M/Z: 702.493


Hit 1 annotations:  PE(16:0/20:5)_[M+H-2H2O]+


在BioDeep NovoCell知识数据库中,参考离子总共被划分为4个级别。
  • Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
  • Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
  • Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
  • Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。

Found 2 Reference Ions Near m/z 702.493
NovoCell ID m/z Mass Window Metabolite Ranking Anatomy Context
MSI_000052577 Unreliable 702.5008 702.5008 ~ 702.5008
MzDiff: none
Not Annotated 1.55 (0%) Homo sapiens
[UBERON:0001052] rectum
MSI_000047238 Unreliable 702.501 702.501 ~ 702.501
MzDiff: none
Ternatin (BioDeep_00000023229)
Formula: C37H67N7O8 (737.5051)
2.51 (100%) Homo sapiens
[UBERON:0013067] colorectal mucosa

Found 3 Sample Hits
Metabolite Species Sample
PE(16:0/20:5)

Formula: C41H72NO8P (737.4995)
Adducts: [M+H-2H2O]+ (Ppm: 10.4)
Homo sapiens (colorectal adenocarcinoma)
80TopL, 50TopR, 70BottomL, 60BottomR-profile
Resolution: 17μm, 137x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

PE(16:0/20:5)

Formula: C41H72NO8P (737.4995)
Adducts: [M+H-2H2O]+ (Ppm: 7.6)
Homo sapiens (colorectal adenocarcinoma)
520TopL, 490TopR, 510BottomL, 500BottomR-profile
Resolution: 17μm, 147x131

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).

PE(16:0/20:5)

Formula: C41H72NO8P (737.4995)
Adducts: [M+H-2H2O]+ (Ppm: 13.1)
Homo sapiens (colorectal adenocarcinoma)
439TopL, 409TopR, 429BottomL, 419BottomR-profile
Resolution: 17μm, 157x136

Description

The human colorectal adenocarcinoma sample was excised during a surgical operation performed at the Imperial College Healthcare NHS Trust. The sample and procedures were carried out in accordance with ethical approval (14/EE/0024).